Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer

• Giulia Schiavoni,
• Beatrice Messina,
• Stefano Scalera,
• Lorenzo Memeo,
• Cristina Colarossi,
• Marzia Mare,
• Giovanni Blandino,
• Gennaro Ciliberto,
• Giulia Bon,
• Marcello Maugeri-Saccà

Affiliations

Giulia Schiavoni

Clinical Trial Center, Biostatistics and Bioinformatics Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute

Beatrice Messina

Clinical Trial Center, Biostatistics and Bioinformatics Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute

Stefano Scalera

SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute

Lorenzo Memeo

Pathology Unit, Mediterranean Institute of Oncology

Cristina Colarossi

Pathology Unit, Mediterranean Institute of Oncology

Marzia Mare

Medical Oncology Unit, Mediterranean Institute of Oncology

Giovanni Blandino

Translational Oncology Research Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute

Gennaro Ciliberto

Scientific Directorate, IRCCS Regina Elena National Cancer Institute

Giulia Bon

Cellular Network and Molecular Therapeutic Target Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute

Marcello Maugeri-Saccà

Clinical Trial Center, Biostatistics and Bioinformatics Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute